Table 1.
Duals Identified through Medicaid Enrollment Files, the State Buy-In Variable, and Both Sources: Distribution by Patient Demographics and Cancer Site, N (% of Total)
| Source |
||||
|---|---|---|---|---|
| Medicaid Enrollment Files | Medicare State Buy-In Variable | Both Sources | Total | |
| Michigan | ||||
| Breast cancer | ||||
| Age group | ||||
| 65–69 | 57 (18.8) | 5 (1.7) | 240 (79.5) | 302 (100.0) |
| 70–74 | 52 (17.2) | 5 (1.7) | 245 (81.1) | 302 (100.0) |
| 75–79 | 67 (23.8) | 2 (0.7) | 212 (75.4) | 281 (100.0) |
| 80–84 | 66 (26.8) | 2 (0.8) | 178 (72.4) | 246 (100.0) |
| 85+ | 76 (34.6) | 4 (1.8) | 140 (63.6) | 220 (100.0) |
| Race | ||||
| African American | 66 (17.5) | 7 (1.9) | 305 (80.7) | 378 (100.0) |
| All other | 252 (25.9) | 11 (1.1) | 710 (73.0) | 973 (100.0) |
| Total | 318 (23.6) | 18 (1.3) | 1,015 (75.1) | 1,351 (100.0) |
| Prostate cancer | ||||
| Age group | ||||
| 65–69 | 42 (16.2) | 6 (2.3) | 211 (81.5) | 259 (100.0) |
| 70–74 | 56 (21.7) | 4 (1.6) | 198 (76.7) | 258 (100.0) |
| 75–79 | 71 (32.7) | 5 (2.3) | 141 (65.0) | 217 (100.0) |
| 80–84 | 77 (52.0) | 3 (2.0) | 68 (46.0) | 148 (100.0) |
| 85+ | 47 (49.0) | 1 (1.0) | 48 (50.0) | 96 (100.0) |
| Race | ||||
| African American | 93 (25.3) | 10 (2.7) | 265 (72.0) | 368 (100.0 |
| All other | 200 (32.8) | 9 (1.5) | 401 (65.7) | 610 (100.0) |
| Total | 293 (30.0) | 19 (1.9) | 666 (68.1) | 978 (100.0) |
| Colorectal cancer | ||||
| Age group | ||||
| 65–69 | 33 (16.3) | 4 (2.0) | 166 (81.8) | 203 (100.0) |
| 70–74 | 50 (19.4) | 5 (1.9) | 203 (78.7) | 258 (100.0) |
| 75–79 | 60 (25.0) | 5 (2.1) | 175 (72.9) | 240 (100.0) |
| 80–84 | 59 (24.3) | 2 (0.8) | 182 (74.9) | 243 (100.0) |
| 85+ | 73 (34.1) | 4 (1.9) | 137 (64.0) | 214 (100.0) |
| Race | ||||
| African American | 62 (18.2) | 6 (1.8) | 272 (80.0) | 340 (100.0) |
| All other | 213 (26.0) | 14 (1.7) | 591 (72.3) | 818 (100.0) |
| Sex | ||||
| Male | 131 (36.2) | 6 (1.7) | 225 (62.2) | 362 (100.0) |
| Female | 144 (18.1) | 14 (1.8) | 638 (80.2) | 796 (100.0) |
| Total | 275 (23.7) | 20 (1.7) | 863 (74.5) | 1,158 (100.0) |
| Ohio | ||||
| Breast cancer | ||||
| Age group | ||||
| 65–69 | 70 (20.1) | 37 (10.6) | 242 (69.3) | 349 (100.0) |
| 70–74 | 68 (14.8) | 63 (13.7) | 329 (71.5) | 460 (100.0) |
| 75–79 | 60 (14.3) | 45 (10.7) | 315 (70.0) | 420 (100.0) |
| 80–84 | 46 (13.2) | 27 (7.7) | 276 (79.1) | 349 (100.0) |
| 85+ | 67 (14.5) | 11 (2.4) | 385 (83.2) | 463 (100.0) |
| Race | ||||
| African American | 73 (17.1) | 48 (11.3) | 305 (71.6) | 426 (100.0) |
| All other | 238 (14.7) | 135 (8.4) | 1,242 (76.9) | 1,615 (100.0) |
| Total | 311 (15.2) | 183 (9.0) | 1,547 (75.8) | 2,041 (100.0) |
| Prostate cancer | ||||
| Age group | ||||
| 65–69 | 47 (21.8) | 29 (13.4) | 140 (64.8) | 216 (100.0) |
| 70–74 | 55 (29.0) | 39 (15.7) | 154 (62.1) | 248 (100.0) |
| 75–79 | 33 (15.6) | 34 (16.1) | 144 (68.3) | 211 (100.0) |
| 80–84 | 25 (15.1) | 8 (4.8) | 133 (80.1) | 166 (100.0) |
| 85+ | 30 (18.9) | 6 (3.8) | 123 (77.4) | 159 (100.0) |
| Race | ||||
| African American | 64 (19.5) | 37 (11.3) | 227 (69.2) | 328 (100.0 |
| All other | 126 (18.8) | 79 (11.8) | 467 (69.5) | 672 (100.0) |
| Total | 190 (19.0) | 116 (11.6) | 694 (69.4) | 1,000 (100.0) |
| Colorectal cancer | ||||
| Age group | ||||
| 65–69 | 65 (23.1) | 32 (11.4) | 184 (65.5) | 281 (100.0) |
| 70–74 | 88 (21.1) | 49 (11.7) | 281 (67.2) | 418 (100.0) |
| 75–79 | 99 (21.1) | 43 (9.2) | 327 (69.7) | 469 (100.0) |
| 80–84 | 58 (15.7) | 24 (6.5) | 287 (77.8) | 369 (100.0) |
| 85+ | 93 (15.3) | 32 (5.3) | 483 (79.4) | 608 (100.0) |
| Race | ||||
| African American | 78 (18.8) | 39 (9.4) | 297 (71.7) | 414 (100.0) |
| All other | 325 (18.9) | 141 (8.2) | 1,265 (73.1) | 1,731 (100.0) |
| Sex | ||||
| Male | 140 (22.9) | 62 (10.2) | 409 (66.9) | 611 (100.0) |
| Female | 263 (17.4) | 118 (7.7) | 1,153 (75.2) | 1,534 (100.0) |
| Total | 403 (18.8) | 180 (8.4) | 1,562 (72.8) | 2,145 (100.0) |